Peptide Surface EngineeringTargeted Liposome DesignTargeted LNP DevelopmentFormulation Screening
At Creative Peptides, we provide custom peptide-modified liposome and lipid nanoparticle (LNP) delivery services for research teams that need controlled surface peptide display, targeted delivery strategy development, and formulation screening support. Our work covers peptide ligand design, peptide-to-lipid coupling, liposome/LNP surface functionalization, and comparative screening workflows for nucleic acids, small molecules, peptides, proteins, and probe cargos. By combining peptide modification services, custom conjugation service, and delivery-focused development support, we help academic, biotech, pharmaceutical, and CRO teams build peptide-decorated carriers for uptake studies, targeting evaluation, mechanism research, and preclinical feasibility work.
Peptide decoration can add real value to liposome and LNP delivery systems, but many projects stall because the peptide, linker, and carrier do not work well together once they are assembled into a nanoparticle. A peptide that binds the intended receptor in solution may lose accessibility on the particle surface, a promising carrier may become unstable after surface modification, or a formulation with strong cellular binding may still show weak functional payload delivery.
Common development problems include:
We support flexible workflows for teams developing peptide-decorated lipid carriers for targeted delivery and screening studies. Projects can start from a client-supplied peptide, a new peptide design, or an existing carrier concept that needs a more practical surface engineering and screening plan. Depending on the project goal, support can be configured as a focused conjugation task or as a broader delivery program integrated with our peptide-based delivery platform.
We begin with a peptide- and carrier-aware design review to define how the sequence should be presented on the particle and what chemistry is most suitable for the project.
This planning step helps avoid rework caused by unsuitable peptide handles, weak surface exposure, or avoidable compatibility problems between the peptide and the carrier.
We support peptide attachment to liposome or LNP surfaces using chemistries selected for sequence compatibility, surface accessibility, and downstream screening needs.
We focus on coupling routes that are practical to execute and easier to verify analytically, rather than treating peptide decoration as a generic add-on step.
For liposome projects, we develop peptide-decorated vesicles with formulation choices aligned to payload class, surface modification route, and intended biological study.
This service is suitable for teams building targeted liposomes for uptake studies, release studies, probe delivery, and comparative carrier evaluation.
For peptide-modified LNP programs, we support formulation and surface engineering strategies designed around the practical behavior of nucleic acid-loaded lipid nanoparticles.
We aim to help teams distinguish between formulations that merely look acceptable by size and those that remain useful after peptide modification and screening.
Because one peptide and one formulation condition rarely answer all delivery questions, we build parallel screening panels to compare practical design variables side by side.
These screening workflows are built to generate decision-supportive data, not just single-batch formulation output.
Peptide-modified lipid carriers need analytical confirmation at both the peptide and particle levels. We provide characterization packages configured to the specific carrier and study goal.
The goal is to give project teams a clearer picture of what was successfully built, what remains heterogeneous, and which formulation variables are worth advancing.
Many peptide-decorated delivery systems require more than one design cycle. We support follow-on optimization after the first build or screening round.
Follow-on options include:
The most suitable peptide engineering route depends on the carrier type, peptide properties, and the readout that matters most to the project. The table below summarizes commonly used display and coupling approaches and the main decision points behind them.
| Surface Engineering Option | Best Fit | Typical Route | When It Is Useful | Key Watchpoint |
|---|---|---|---|---|
| Pre-conjugated Lipid-Peptide | Liposomes and selected LNP workflows | Peptide coupled to a lipid anchor or PEG-lipid before carrier assembly | Useful when defined composition and a fixed peptide presentation strategy are required from the start | Peptide hydrophobicity or high anchor loading can shift size distribution and recovery |
| Post-Insertion Display | Preformed liposomes and some preformed LNPs | Ligand-lipid micelles inserted after carrier formation | Useful when the base formulation is already established and several peptide options need rapid comparison | Insertion efficiency and true surface accessibility should be verified rather than assumed |
| Direct Covalent Coupling | Reactive liposome surfaces and functional PEG-lipid systems | Maleimide-thiol, NHS-amine, oxime, or related conjugation chemistry | Useful when site-selective coupling, lower-density decoration, or controlled peptide orientation is important | Reaction conditions must be tuned to limit aggregation, hydrolysis, or payload loss |
| SPAAC / Click Linkage | Azide- or alkyne-ready liposome and LNP systems | Copper-free click coupling between peptide and surface anchor | Useful when orthogonality is needed or free thiols on the peptide are limited | Handle size and spacer architecture can affect purification and surface exposure |
| Lipidated Peptide Insertion | Liposomes and membrane-active formulations | Cholesterol, fatty acid, or other lipid-bearing peptide insertion into the membrane | Useful for membrane anchoring, fusogenic support, or direct insertion studies | Over-insertion can disturb bilayer behavior and increase leakage or aggregation risk |
| Dual-Peptide Display | Comparative liposome and LNP screening programs | Receptor-targeting peptide combined with CPP, fusogenic, or helper peptide element | Useful when receptor binding alone does not produce sufficient intracellular delivery | Peptide density balance and sequence compatibility are critical to avoid unstable formulations |
Screening is most useful when it connects formulation variables to a clear decision. The table below outlines practical variables we commonly compare for peptide-modified liposomes and LNPs, along with the readouts that help move a project forward.
| Screening Objective | Variables Compared | Typical Readouts | Why It Matters | Common Decision Outcome |
|---|---|---|---|---|
| Preserve Colloidal Stability | Peptide density, anchor ratio, insertion temperature, buffer, purification route | Size, PDI, zeta potential, visual appearance, short-term stability | Unstable particles can create misleading biology and poor batch reproducibility | Remove high-loading or poorly tolerated modification conditions |
| Improve Surface Accessibility | Spacer length, PEG length, coupling site, anchor type | Binding assay results, fluorescence accessibility, comparative uptake | A peptide can be present on the particle but still remain functionally hidden | Select the display format with more usable receptor engagement |
| Protect Payload Integrity | Lipid composition, loading method, peptide insertion sequence, cleanup method | Encapsulation efficiency, leakage, recovery, release-related behavior | Surface modification should not undermine the payload the carrier was built to deliver | Prioritize formulations that balance modification with payload retention |
| Differentiate Uptake vs Function | Peptide type, display density, helper sequence, cell model | Imaging or flow uptake data alongside reporter expression, knockdown, or release endpoints | Strong binding alone does not guarantee useful intracellular delivery | Advance formulations with better functional delivery, not just stronger association |
| Tune LNP Composition | Ionizable lipid, helper lipid, cholesterol, PEG-lipid ratio, N/P ratio | Size, encapsulation, transfection or silencing readouts, formulation robustness | Peptide modification often interacts with the core LNP composition rather than acting independently | Narrow the composition window before larger optimization rounds |
| Tune Liposome Composition | Phospholipid type, cholesterol level, PEG-lipid content, peptide anchor level | Loading behavior, membrane stability, release trend, uptake comparison | Liposome performance depends on membrane composition as much as peptide selection | Select the membrane composition best suited to the intended cargo and study model |
| Check Storage Robustness | Buffer system, cryoprotectant, serum exposure, freeze-thaw conditions | Size drift, recovery, signal retention, peptide stability | Handling conditions can erase apparent gains seen in freshly prepared particles | Define practical storage and transport conditions for follow-on studies |
Peptide-First Design
We start from peptide sequence properties, surface presentation needs, and coupling constraints instead of treating the peptide as a generic ligand.
Carrier-Specific Chemistry
Surface engineering plans are adjusted for the practical differences between liposomes and LNPs, including formulation route, lipid composition, and purification behavior.
Targeting-Focused Screening
We help compare peptide density, spacer design, and formulation composition in screening-friendly formats that support real development decisions.
Liposome and LNP Coverage
Teams can evaluate liposome and LNP options within one service framework when the most suitable carrier is still being selected.
Orthogonal Analytics
We combine particle-level and peptide-level characterization so that formulation performance is interpreted with better technical context.
Flexible Project Scope
Support can range from a defined surface conjugation task to multi-round optimization with formulation screening and follow-on material supply.
Our workflow is designed to move from peptide and carrier assessment to a screened, characterized delivery system that is ready for research use and follow-on optimization.
1
Project Review & Input Definition
2
Peptide & Coupling Route Selection
3
Carrier Build & Surface Engineering
4
Screening & Characterization
5
Optimization & Delivery
Peptide-decorated lipid carriers are useful when a project needs more than passive delivery. Below are representative research directions where peptide-modified liposome and LNP services can support design, screening, and technical comparison.
If your team is developing a peptide-decorated liposome or LNP and needs support with surface modification, targeting strategy, or formulation screening, Creative Peptides can provide practical chemistry, formulation development, and analytical support aligned to your research goals. We can work from your existing peptide and carrier concept or help build a new workflow around the intended target, payload, and screening endpoint. Contact us today to discuss your peptide sequence, carrier type, modification route, and project scope.
Yes. We can support liposome-only, LNP-only, or comparative projects when the better carrier format is still under evaluation.
Yes. We can start from a client-supplied peptide, a peptide-lipid conjugate, or a new sequence that needs design review and modification planning.
Common options include thiol-maleimide, NHS-amine, oxime, and copper-free click strategies, selected according to sequence compatibility and carrier format.
Yes. When technically appropriate, we can compare both approaches to see how they affect peptide accessibility, particle stability, and delivery-related readouts.
Screening can include peptide density, spacer length, anchor type, lipid composition, PEG-lipid level, N/P ratio, buffer system, and purification method.
